Viatrexx-Pigmentation
- Product NDC
- 73069-410
- 11-digit product format
- 730690410
- Labeler code
- 73069
- Product ID
- 73069-410_2e18673b-0eaa-4704-a385-4ab3f43e05e6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Adrenal, Azelaic, Copper, Cutis, Cysteine, Epithelial GF, Fumaric acid, Glutathione, Glycolic acid, Kalium aspariticum, Lymph node, Melanine, Natrum oxalaceticum, Natrum pyruvicum, Phenylalanin, Quinhydrone, Succinic acid, Thuja, Tyrosine, Vitamin C, Zinc
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR; INTRAVENOUS; PARENTERAL; SUBCUTANEOUS
- Labeler
- VIATREXX BIO INCORPORATED
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start
- 2019-03-29
- Marketing end
- 0000-00-00
- Substance
- SUS SCROFA ADRENAL GLAND; BOS TAURUS ADRENAL GLAND; AZELAIC ACID; BOS TAURUS SKIN; COPPER; CYSTEINE; FUMARIC ACID; GLUTATHIONE; GLYCOLIC ACID; POTASSIUM ASPARTATE; NEPIDERMIN; SUS SCROFA LYMPH VESSEL; BOS TAURUS LYMPH VESSEL; SODIUM DIETHYL OXALACETATE; SODIUM PYRUVATE; PHENYLALANINE; QUINHYDRONE; SUCCINIC ACID; THUJA OCCIDENTALIS LEAFY TWIG; TYROSINE; ASCORBIC ACID; ZINC; MELANIN SYNTHETIC (TYROSINE, PEROXIDE); SUS SCROFA SKIN
- Active strength
- 31 [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL
- Pharmacologic classes
- Decreased Protein Synthesis [PE],Decreased Sebaceous Gland Activity [PE],Non-Standardized Animal Skin Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Cells, Epidermal [EXT],Allergens [CS],Copper [CS],Copper-containing Intrauterine Device [EPC],Decreased Embryonic Implantation [PE],Decreased Sperm Motility [PE],Inhibit Ovum Fertilization [PE],Melanin Synthesis Inhibitor [EPC],Melanin Synthesis Inhibitors [MoA],Depigmenting Activity [PE],Vitamin C [EPC],Ascorbic Acid [CS],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Cells, Epidermal [EXT],Allergens [CS],Non-Standardized Animal Skin Allergenic Extract [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record